Your browser doesn't support javascript.
loading
Prediction and Reduction of the Aggregation of Monoclonal Antibodies.
van der Kant, Rob; Karow-Zwick, Anne R; Van Durme, Joost; Blech, Michaela; Gallardo, Rodrigo; Seeliger, Daniel; Aßfalg, Kerstin; Baatsen, Pieter; Compernolle, Griet; Gils, Ann; Studts, Joey M; Schulz, Patrick; Garidel, Patrick; Schymkowitz, Joost; Rousseau, Frederic.
Afiliação
  • van der Kant R; VIB Switch Laboratory, Herestraat 49, B-3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, PO 802, B-3000 Leuven, Belgium.
  • Karow-Zwick AR; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Van Durme J; VIB Switch Laboratory, Herestraat 49, B-3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, PO 802, B-3000 Leuven, Belgium.
  • Blech M; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Gallardo R; VIB Switch Laboratory, Herestraat 49, B-3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, PO 802, B-3000 Leuven, Belgium.
  • Seeliger D; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Aßfalg K; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Baatsen P; EM-platform VIB Bio Imaging Core, VIB-KU Leuven, Herestraat 49, B-3000 Leuven.
  • Compernolle G; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Herestraat 49, PO 820, B-3000 Leuven, Belgium.
  • Gils A; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Herestraat 49, PO 820, B-3000 Leuven, Belgium.
  • Studts JM; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Schulz P; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Garidel P; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach/Riss, Germany.
  • Schymkowitz J; VIB Switch Laboratory, Herestraat 49, B-3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, PO 802, B-3000 Leuven, Belgium. Electronic address: joost.schymkowitz@switch.vib-kuleuven.be.
  • Rousseau F; VIB Switch Laboratory, Herestraat 49, B-3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, PO 802, B-3000 Leuven, Belgium. Electronic address: frederic.rousseau@switch.vib-kuleuven.be.
J Mol Biol ; 429(8): 1244-1261, 2017 04 21.
Article em En | MEDLINE | ID: mdl-28322916
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biologia Computacional / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Mol Biol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biologia Computacional / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Mol Biol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica